Dr. Lindsay Ann Grotting, MD

Dr. Grotting practices at Seaside Surgical Center Inc in Torrance, California.

Dr. Grotting's NPI, 1164721619, was assigned on March 23, 2011. Dr. Grotting graduated from Georgetown University School Of Medicine in 2011. Dr. Grotting's Massachusetts license number on file is 262154.

Dr. Grotting's primary practice is Seaside Surgical Center Inc, at 4201 Torrance Blvd, Torrance, CA 90503 in Los Angeles County. The practice phone is (310) 540-0144.

Dr. Grotting's primary practice is Seaside Surgical Center Inc in Torrance, California. Dmand AI also links Dr. Grotting to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grotting practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Grotting's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Grotting is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Grotting's licenses on file in 3 states: Massachusetts, California and Illinois.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, eyelid inflammation, glaucoma, hypertensive retinopathy, inflammation of iris and retinal detachment among the conditions Dr. Grotting treats.

CMS data shows 9,605 Medicare services from Dr. Grotting across 14 procedure codes in 2024, for 320 Medicare patients. Medicare paid $871,791 for them. Every service was in an office.

CMS counts 320 Medicare patients who saw Dr. Grotting in 2024. The largest group is 75 to 84, with 132 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grotting's median patient age at 62, with 64% women.

In 2024, Dr. Grotting wrote 1,152 Medicare Part D claims for 215 patients. 64% of them were for generic drugs. CMS names the drug for 1,061 of them, across 24 drugs with 11 or more claims each, at $97,171 in total drug cost. In 2023, CMS named 998 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Grotting for performance year 2024, reported as part of a group. Dr. Grotting accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Grotting, published from 2016 to 2018. 2016 was the busiest year, with 2. The most frequent topics are Visual Acuity, Uveitis and Vitamin D. Dr. Grotting's most frequent co-authors are Lucia Sobrin, MD, MPH, Avni Patel Finn, MBA, MD and Lisa Michelle Tom, MD.

CMS Open Payments shows 34 general payments to Dr. Grotting from 16 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 56% of the total. Aerie Pharmaceuticals, Inc. paid the most, $524.

Dmand AI lists 1 award for Dr. Grotting, most recently AOA Inductee 2011 in 2011.

Dr. Grotting graduated from Georgetown University School Of Medicine in 2011. Dr. Grotting is a member of AOA.

Dr. Grotting is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.